Currently, Precigen Inc’s (PGEN) stock is trading at $4.85, marking a gain of 7.63% from last night’s close. At this price, the stock is 0.60% below its 52-week high of $4.82 and 645.28% above its 52-week low of $0.65. Based on the past 30-day period, the stock price is -0.69% below the high and +186.54% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, PGEN’s SMA-200 is $1.57.
How does Precigen Inc (PGEN) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 5 brokerage firms that recommend the stock as a Moderate Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.20 in simple terms.
Precigen Inc (PGEN): Earnings History
If we examine Precigen Inc’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of -$0.08, slashing the consensus of -$0.08. In other words, it beat the consensus by $0, resulting in a 4.12% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of -$0.08 in contrast with the Outlook of -$0.08. That was a difference of $0 and a surprise of 4.12%.
Precigen Inc (PGEN): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 2 different analysts, who are expecting earnings to fall in between the range of -0.07 and -0.09 with an average Earnings Estimate of -0.08 which is in contrast with the last year earnings estimate of -0.09 and also replicates 11.11% growth rate year over year.
Precigen Inc (NASDAQ: PGEN) Ownership Details
I will give a breakdown of the key shareholders in Precigen Inc (PGEN). Recent figures show that the company’s insiders hold 10.47% of shares. A total of 191 institutional investors hold shares in the company, making 66.80% of its stock and 74.61% of its float.
Jun 30, 2025, it was reported that the Company’s largest institutional holder is Advisor Managed Portfolios-Patient Opportunity Trust holding total of 12.8 shares that make 4.30% of the company’s total number of shares and are currently priced at 60.99 million.
The securities firm VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds 5.45 shares of PGEN, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 1.83%, and the holding percentage of shares is valued at 25.99 million.
An overview of Precigen Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Precigen Inc (PGEN) traded 17,298,932 shares per day, with a moving average of $3.08 and price change of +3.11. With the moving average of $2.23 and a price change of +3.42, about 8,590,181 shares changed hands on average over the past 50 days. Finally, PGEN’s 100-day average volume is 5,091,205 shares, alongside a moving average of $1.83 and a price change of +3.70.
